UA80870C2 - Method for treatment or prevention of aspergillus infections with thymosin alpha 1 - Google Patents

Method for treatment or prevention of aspergillus infections with thymosin alpha 1

Info

Publication number
UA80870C2
UA80870C2 UAA200509921A UA2005009921A UA80870C2 UA 80870 C2 UA80870 C2 UA 80870C2 UA A200509921 A UAA200509921 A UA A200509921A UA 2005009921 A UA2005009921 A UA 2005009921A UA 80870 C2 UA80870 C2 UA 80870C2
Authority
UA
Ukraine
Prior art keywords
thymosin alpha
prevention
treatment
aspergillus
aspergillus infections
Prior art date
Application number
UAA200509921A
Other languages
English (en)
Original Assignee
Sciclone Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sciclone Pharmaceuticals Inc filed Critical Sciclone Pharmaceuticals Inc
Publication of UA80870C2 publication Critical patent/UA80870C2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2292—Thymosin; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA200509921A 2003-03-28 2004-03-29 Method for treatment or prevention of aspergillus infections with thymosin alpha 1 UA80870C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45791103P 2003-03-28 2003-03-28
PCT/US2004/009550 WO2004087067A2 (en) 2003-03-28 2004-03-29 Treatment of aspergillus infections with thymosin alpha 1

Publications (1)

Publication Number Publication Date
UA80870C2 true UA80870C2 (en) 2007-11-12

Family

ID=42828702

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200509921A UA80870C2 (en) 2003-03-28 2004-03-29 Method for treatment or prevention of aspergillus infections with thymosin alpha 1

Country Status (17)

Country Link
US (2) US8207294B2 (de)
EP (1) EP1613340B1 (de)
JP (1) JP4629033B2 (de)
KR (1) KR101089145B1 (de)
AT (1) ATE467422T1 (de)
AU (1) AU2004226403B2 (de)
BR (1) BRPI0408892A (de)
CA (1) CA2520400C (de)
DK (1) DK1613340T3 (de)
EA (1) EA008037B1 (de)
IL (1) IL171118A (de)
MX (1) MXPA05010391A (de)
NO (1) NO329997B1 (de)
NZ (1) NZ542900A (de)
PL (1) PL1613340T3 (de)
UA (1) UA80870C2 (de)
WO (1) WO2004087067A2 (de)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2801808C1 (ru) * 2022-03-14 2023-08-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ хирургического лечения крупных подплеврально расположенных туберкулезных каверн легких, не дренируемых бронхом

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0408892A (pt) 2003-03-28 2006-04-11 Sciclone Pharmaceuticals Inc uso de timosina alfa 1 para tratar as infecções por arpergillus
CN101072582B (zh) * 2004-12-06 2012-06-27 赛生制药有限公司 作为癌症疫苗佐剂的α胸腺肽
AU2007253527B2 (en) * 2006-05-19 2012-04-26 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1 for the treatment of immunological diseases
ITRM20060583A1 (it) * 2006-10-27 2008-04-28 Francesco Bistoni Uso della timosina alfa 1 per la preparazione di un medicamento per la prevenzione e la cura delle allergie
EP2675272A4 (de) * 2011-02-09 2015-03-11 Sciclone Pharmaceuticals Inc Thymosin-alpha-peptid zur prävention, linderung und behandlung von infektionen
ITUB20153714A1 (it) * 2015-09-18 2017-03-18 Luigina Romani Timosina alfa 1 per l?uso nel trattamento della fibrosi cistica.
BR112017016205A2 (pt) * 2015-02-09 2018-03-27 Romani Luigina thymosin alpha 1 para uso no tratamento de fibrose cística

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002740A (en) * 1975-08-21 1977-01-11 Gideon Goldstein Tridecapeptide compositions and methods
US4079127A (en) * 1976-10-28 1978-03-14 Board Of Regents Of The University Of Texas Thymosin alpha 1
US4116951A (en) * 1977-04-22 1978-09-26 Hoffmann-La Roche Inc. [Asn2 ]-thymosin α1 and analogs thereof
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
US4612365A (en) * 1980-03-25 1986-09-16 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften Medicaments containing alpha 1-thymosin and having an immuno regulatory action and alpha 1-thymosin fragments
US4374197A (en) * 1980-10-30 1983-02-15 Hoffmann-La Rocche Inc. Process for thymosin α1
TW224053B (de) * 1991-09-13 1994-05-21 Paul B Chretien
CN1058500C (zh) * 1993-02-03 2000-11-15 施塞克龙药品公司 胸腺素α－1衍生物
CN1072961C (zh) 1993-03-05 2001-10-17 施塞克龙药品公司 治疗对干扰素治疗无反应者的丙型肝炎的方法
TW252045B (de) * 1993-10-07 1995-07-21 Allan L Goldstein
RU2107692C1 (ru) * 1995-06-07 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US5888980A (en) * 1994-06-30 1999-03-30 Bio-Logic Research And Development Corporation Compositions for enhancing immune function
US5632983A (en) 1994-11-17 1997-05-27 University Of South Florida Method for treating secondary immunodeficiency
WO1998035696A1 (en) * 1997-02-18 1998-08-20 Sciclone Pharmaceuticals, Inc. Use of thymosin alpha 1 for the manufacture of a medicament for promoting stem cell development
UA80957C2 (en) * 2001-11-01 2007-11-26 Sciclone Pharmaceuticals Inc Method of administering a thymosin alpha 1 peptide
BRPI0408892A (pt) 2003-03-28 2006-04-11 Sciclone Pharmaceuticals Inc uso de timosina alfa 1 para tratar as infecções por arpergillus

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2801808C1 (ru) * 2022-03-14 2023-08-15 Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр фтизиопульмонологии и инфекционных заболеваний" Министерства здравоохранения Российской Федерации (ФГБУ "НМИЦ ФПИ" Минздрава России) Способ хирургического лечения крупных подплеврально расположенных туберкулезных каверн легких, не дренируемых бронхом

Also Published As

Publication number Publication date
US8389680B2 (en) 2013-03-05
NO20054912L (no) 2005-12-20
CA2520400A1 (en) 2004-10-14
JP4629033B2 (ja) 2011-02-09
KR101089145B1 (ko) 2011-12-02
PL1613340T3 (pl) 2010-10-29
US20120295840A1 (en) 2012-11-22
CA2520400C (en) 2013-02-19
NO329997B1 (no) 2011-02-07
US8207294B2 (en) 2012-06-26
EP1613340A4 (de) 2009-07-01
EP1613340A2 (de) 2006-01-11
MXPA05010391A (es) 2005-11-04
BRPI0408892A (pt) 2006-04-11
NO20054912D0 (no) 2005-10-24
WO2004087067A3 (en) 2004-12-29
AU2004226403B2 (en) 2008-12-04
JP2006521406A (ja) 2006-09-21
ATE467422T1 (de) 2010-05-15
EA008037B1 (ru) 2007-02-27
EP1613340B1 (de) 2010-05-12
AU2004226403A1 (en) 2004-10-14
NZ542900A (en) 2007-06-29
WO2004087067A2 (en) 2004-10-14
EA200501414A1 (ru) 2006-04-28
IL171118A (en) 2011-10-31
US20070129292A1 (en) 2007-06-07
DK1613340T3 (da) 2010-08-30
KR20050114264A (ko) 2005-12-05

Similar Documents

Publication Publication Date Title
NO20055722D0 (no) Antiseptiske preparater, fremgangsmater og systemer
EP2308963A3 (de) System zur Behandlung von Zellen aus Lipoaspirat
ATE319312T1 (de) Suppressorzellen zur prävention und behandlung von immunantworten bei transplantationen
EP2011489A3 (de) Verfahren zur Prävention von Ischämie/Reperfusionsschaden
WO2004074457A3 (en) Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
DK1373215T3 (da) Gelanamycinderivater egnet til behandling af cancer
ATE531419T1 (de) Vorrichtung zur verabreichung von therapeutischen mitteln
UA88463C2 (ru) Фармацевтическая композиция, которая содержит соединение 1, и процесс лечения вич-инфекции
MXPA01010982A (es) Uso de phyllanthus para la estimulacion dirigida al objetivo del sistema inmune.
PT1565201T (pt) Métodos de administração de dalbavancina para o tratamento de infeções bacterianas
EA201100413A1 (ru) Способ лечения бактериальной инфекции
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
EP1613340A4 (de) Behandlung von aspergillus-infektionen mit thymosin alpha 1
EP1620061A4 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
PT1237562E (pt) Processo de preparacao de extractos de micania contendo micanolida e di-hidromicanolida e utilizacao no tratamento das doencas proliferativas
WO2004009029A3 (en) Compositions and methods for treating and preventing infection
NZ512850A (en) Treatment of papillomavirus infections
MXPA05004121A (es) Metodos para tratar la enfermedad de ojo reseco con lantibioticos.
WO2005000239A3 (en) Lyase treatment for p. carinii
AU2003300023A1 (en) Method for treating an environment that may be or is contaminated with an undesirable bacteria, virus and/or spore
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection
CY1110218T1 (el) Αγωγη των λοιμωξεων απο ασπεργιλλο με θυμοσινη αλφα 1
AU2003304316A8 (en) Compounds and methods for the treatment and prevention of bacterial infection
UA34333A (uk) Спосіб лікування тяжких форм флюорозу зубів
UA32314A (uk) Спосіб лікування некротичного панкреатиту